Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Papillomavirus Infections 1 Carcinoma in Situ 1 Breast Diseases 1 Agnosia 1

Interventions

exemestane 7 Trastuzumab 7 Anastrozole 7 Letrozole 6 Docetaxel 6 palbociclib 5 pyrotinib 4 entinostat 4 Fulvestrant 4 Cyclophosphamide 4 ribociclib 3 abemaciclib 3 Tamoxifen 3 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Aromatase Inhibitors 2 AZD9833 2 trastuzumab deruxtecan 1 taxane 1 sacubitril and valsartan sodium hydrate drug combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Diseases × Codeine × Clear all

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡